Shanlian Hu - Concepedia

Author

Shanlian Hu

Fudan University ORCID

Also Known As

Hu Shanlian, Hu, S.L., Hu, Shanlian, Hu, Siying, James Smeeding, S Hu, S L Hu, S. Hu, S.L. Hu, SHAN-LIAN HU

124

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Fudan University Development Research Center Shanghai Medical Information Center Shanghai Public Health Clinical Center Pfizer (China)

About

Shanlian Hu is an author at Fudan University specializing in medicine, health policy, and health economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	242
2	Health Sciences	3	3	87
3	Business	2	2	78
4	Engineering	1	1	28
5	Management	1	1	28

Shanlian Hu

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Reform of how health care is paid for in China: challenges and opportunities Shanlian Hu, Shenglan Tang, Yuanli Liu, The Lancet Health Insurance ReformPrimary CareHealth ReformHealthcare ProvisionHealth Policy	2008	456
Non‐A, non‐b hepatitis in persistent carriers of hepatitis b virus K. N. Tsiquaye, G. Tovey, H. Kessler, Journal of Medical Virology	1983	71
Health-Care Systems and Pharmacoeconomic Research in Asia-Pacific Region Yen-Huei Tarn, Shanlian Hu, Isao Kamae, Value in Health Health SystemsHealth PolicyHealth EconomicsPharmaceutical CarePharmacoeconomics	2008	60
Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions Hong Li, Gordon G. Liu, Jing Wu, Value in Health Regional Issues Preclinical TherapeuticsPharmacotherapyHealth Care FinancePharmaceutical PracticeClinical Trials	2018	53
Is community financing necessary and feasible for rural China? Yuanli Liu, Shanlian Hu, Wei Fu, Health Policy EconomicsPublic PolicyCommunity DevelopmentRural DevelopmentRural Economy	1996	50
Essential medicine policy in China: pros and cons Shanlian Hu Journal of Medical Economics	2012	40
Factors associated with the decline of the Cooperative Medical System and barefoot doctors in rural China. Naisu Zhu, Zhihua Ling, Jay J. Shen, PubMed NursingFamily MedicineHealth AdministrationPrimary CareHealthcare Provision	1989	39
Guidance Document: Global Pharmacoeconomic Model Adaption Strategies C. Daniel Mullins, Nneka C. Onwudiwe, Gabriela Tannus Branco de Araújo, Value in Health Regional Issues Guidance DocumentEconomicsHealth EconomicsGlobal HealthInternational Health	2014	36
National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities Worasuda Yoongthong, Shanlian Hu, Jennifer A. Whitty, Value in Health Substance AbuseHealth PolicyHealth EconomicsNational Drug PoliciesDrug Listing Changes	2012	29
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets Diana Brixner, Nikos Maniadakis, Zoltán Kaló, Value in Health Regional Issues Method ValidationSimple ScoringEngineeringBusiness IntelligenceManagement	2017	28

Page 1